Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’
Nearly 40% of adults are at risk of fatty liver disease which has emerged as...
Tag : Zydus Lifesciences
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a...
Zydus Lifesciences initiates Phase II clinical trial of ZYIL1, a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)
The Phase 2 clinical trial will assess the safety and efficacy of ZYIL1 in Amyotrophic...